To examine whether inactivation of TGF-β signaling influences the organization of tumor blood vessels, tumor sections were co-stained for CD31/PECAM, an endothelium marker, and NG2/CSPG4, a marker of pericytes, blood vessel-supporting cells (Fig. 4). Here, TGFB1 is linked to neoplasm.